-+ 0.00%
-+ 0.00%
-+ 0.00%

Prelude Therapeutics FY Sales $7.000M Beat $2.000M Estimate

Benzinga·03/10/2025 11:46:10
Listen to the news
Prelude Therapeutics (NASDAQ:PRLD) reported quarterly sales of $7.000 million which beat the analyst consensus estimate of $2.000 million by 250.00 percent.